Lyra Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Lyra Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
  • Lyra Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $136K, a 52.1% decline year-over-year.
  • Lyra Therapeutics, Inc. annual Depreciation for 2023 was $278K, a 73.9% decline from 2022.
  • Lyra Therapeutics, Inc. annual Depreciation for 2022 was $1.07M, a 6.59% increase from 2021.
  • Lyra Therapeutics, Inc. annual Depreciation for 2021 was $1M, a 954% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $136K -$148K -52.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q1 2023 $1.07M $284K +$4K +1.43% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $1.07M $187K -$44K -19% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 $1.11M $300K -$100K -25% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $1.21M $300K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q/A 2022-11-02
Q1 2022 $1.21M $280K +$210K +300% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $1M $231K +$190K +463% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $811K $400K +$367K +1112% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $444K $300K +$287K +2208% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-02
Q1 2021 $157K $70K +$62K +775% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-11-02
Q4 2020 $95K $41K +$34K +486% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 $61K $33K +$27K +450% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $34K $13K +$7K +117% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $27K $8K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $27K $7K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $6K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $6K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $8K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.